Upregulation of interferon-γ response genes in monocytes and T cells identified by single-cell transcriptomics in patients with anti-citrullinated peptide antibody-positive early rheumatoid arthritis

被引:0
|
作者
Hong, Bong-Ki [1 ]
You, Sungyong [2 ]
Kim, Jung Gon [1 ,3 ]
Kim, Minhyung [2 ]
Lee, Naeun [1 ]
Lee, Kijun [4 ,5 ]
Baek, In-Pyo [5 ]
Ju, Ji Hyeon [4 ,5 ,6 ]
Kim, Wan-Uk [1 ,6 ]
Kim, Ho-Youn [7 ]
机构
[1] Catholic Univ Korea, Ctr Integrat Rheumatoid Transcript & Dynam, Seoul, South Korea
[2] Cedars Sinai Med Ctr, Urol & Computat Biomed, Los Angeles, CA USA
[3] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Div Rheumatol, Goyang, South Korea
[4] Catholic Univ Korea, Coll Med, Catholic iPSC Res Ctr, Seoul, South Korea
[5] YiPSCELL Inc, Seoul, South Korea
[6] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea
[7] Catholic Univ Korea, Ho Youn Kims Clin Arthrit Rheumatism, Seoul, South Korea
来源
FRONTIERS IN IMMUNOLOGY | 2025年 / 15卷
基金
新加坡国家研究基金会;
关键词
single-cell transcriptomics; peripheral blood mononuclear cells; anti-citrullinated peptide antibody; rheumatoid arthritis; rheumatoid arthritis pathogenesis; Th1; immunity; interferon signature; IFITM2/3; I INTERFERONS; ALPHA; AUTOANTIBODIES; EXPRESSION; RETENTION; RECEPTORS; SIGNATURE; COLLEGE;
D O I
10.3389/fimmu.2024.1439082
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction Our aim was to investigate the insufficiently understood differences in the immune system between anti-citrullinated peptide antibody (ACPA)-positive (ACPA+) and ACPA-negative (ACPA-) early rheumatoid arthritis (eRA) patients.Methods We performed multiple cytokine assays using sera from drug-na & iuml;ve ACPA+ and ACPA- eRA patients. Additionally, we conducted single-cell RNA sequencing of CD45+ cells from peripheral blood samples to analyze and compare the distribution and functional characteristics of the cell subsets based on the ACPA status.Results Serum concentrations of interferon-gamma (IFN-gamma) and interleukin (IL)-12 were higher in ACPA+ eRA than in ACPA- eRA. Single-cell transcriptome analysis of 37,318 cells identified 17 distinct cell types and revealed the expansion of IL1B+ proinflammatory monocytes, IL7R+ T cells, and CD8+ CCL4+ T cells in ACPA+ eRA. Furthermore, we observed an enrichment of IFN-gamma response genes in nearly all monocytes and T cells of ACPA+ eRA subsets. Heightened interactions between IFN-gamma and IFN-gamma receptors were observed in ACPA+ eRA, particularly between monocytes and T cells. We examined IFITM2 and IFITM3 as potential key markers in ACPA+ eRA given their pronounced upregulation and association with the IFN response. Specifically, the expression of these genes was elevated in IL1B+ proinflammatory monocytes (likely M1 monocytes), correlating with serum IFN-gamma levels.Discussion Compared to ACPA- eRA, ACPA+ eRA showed higher serum IFN-gamma and IL-12 levels, upregulated IFN-gamma response genes, and enhanced IFN-gamma-driven monocyte-T cell interactions. These distinct immune features of the peripheral circulation in ACPA+ eRA suggest a role for type 1 helper T cell-related immunity in its pathogenesis.
引用
收藏
页数:15
相关论文
共 48 条
  • [21] THE IMPACT OF EARLY TREATMENT WITH ADALIMUMAB ON RHEUMATOID FACTOR AND ANTI-CITRULLINATED PEPTIDE ANTIBODY LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE OPTIMA TRIAL
    Smolen, J. S.
    Kavanaugh, A.
    Aletaha, D.
    Florentinus, S.
    Li, Y.
    Lagunes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 229 - 230
  • [22] RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS DIFFERS DEPENDING ON RHEUMATOID FACTOR LEVELS IN ANTI-CITRULLINATED POSITIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Bugatti, S.
    Manzo, A.
    Zanframundo, G.
    Benaglio, F.
    Sakellariou, G.
    Montecucco, C.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 790 - 791
  • [23] The PTPN221858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
    Heidi Kokkonen
    Martin Johansson
    Lena Innala
    Erik Jidell
    Solbritt Rantapää-Dahlqvist
    Arthritis Research & Therapy, 9
  • [24] HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles
    Nordang, Gry B. N.
    Flam, Siri T.
    Maehlen, Marthe T.
    Kvien, Tore K.
    Viken, Marthe K.
    Lie, Benedicte A.
    RHEUMATOLOGY, 2013, 52 (11) : 1973 - 1982
  • [25] Risk of progression from undifferentiated arthritis to rheumatoid arthritis:: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients
    Feitsma, A. L.
    Toes, R. E. M.
    Begovich, A. B.
    Chokkalingam, A. P.
    de Vries, R. R. P.
    Huizinga, T. W. J.
    van der Helm-van Mil, A. H. M.
    RHEUMATOLOGY, 2007, 46 (07) : 1092 - 1095
  • [26] Preferential Distribution of M1 Monocytes in Anti-Cyclic Citrullinated Peptide Antibody Positive Patients with Rheumatoid Arthritis
    Fukui, Shoichi
    Iwamoto, Naoki
    Shimizu, Toshimasa
    Umeda, Masataka
    Nishino, Ayako
    Horai, Yoshiro
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Ichinose, Kunihiro
    Hirai, Yasuko
    Tamai, Mami
    Nakamura, Hideki
    Origuchi, Tomoki
    Kawakami, Atsushi
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [27] DISEASE REMISSION IS MORE COMMON BUT LESS STRINGENT IN ANTI-CITRULLINATED PROTEIN ANTIBODY-POSITIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS TREATED WITH CONVENTIONAL SYNTHETIC DISEASE MODIFYING DRUGS
    Manzo, A.
    Bugatti, S.
    Zanframundo, G.
    Benaglio, F.
    Sakellariou, G.
    Montecucco, C.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 565 - 565
  • [28] Symptom Burden in Anti-citrullinated Protein Antibody Positive Individuals At-risk for Rheumatoid Arthritis Is Changing over Time and Comparable to Patients with Early Rheumatoid Arthritis
    Studenic, Paul
    Circiumaru, Alexandra
    Aletaha, Daniel
    Chatzidionysiou, Katerina
    Catrina, Anca
    Hensvold, Aase Haj
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3446 - 3448
  • [29] Erratum To: The PTPN221858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
    Heidi Kokkonen
    Martin Johansson
    Lena Innala
    Erik Jidell
    Solbritt Rantapää-Dahlqvist
    Arthritis Research & Therapy, 9
  • [30] The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
    Kokkonen, Heidi
    Johansson, Martin
    Innala, Lena
    Jidell, Erik
    Rantapaa-Dahlqvist, Solbritt
    ARTHRITIS RESEARCH & THERAPY, 2007, 9 (03)